Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London on 23 April, 2026 for the 22nd Annual Anglonordic Life Science Conference.

The Reception, our must-attend networking event, will take place, as always, the evening before the conference at a prestigious London venue.

The conference Programme features on-point panel discussions around European investment and technologies, with 36 funding pitches presented by cutting-edge biomedical and healthcare startups, and 1:1 partnering throughout the day. More than 86 high quality investor firms attended the 2025 conference and we expect a similar number in April.

With the support of M Ventures as lead and founding sponsor, and rich, engaging content devised and coordinated by Optimum Strategic Communications, Anglonordic a top networking and partnering event in the life sciences calendar, and the unique R&D-to-investor conference in the UK.

Keynote Speaker: Laura Matz, Merck

Dr. Laura Matz is the Chief Science and Technology Officer at Merck, where she drives innovation and digitalization across Life Sciences, Healthcare, and Electronics.
As Executive Vice President, she oversees corporate innovation teams, including new business models. Until early 2025, Laura was also the CEO of Athinia®, a data-sharing platform that enables secure data sharing within the semiconductor ecosystem. Prior to this, she was a Senior Vice President at EMD Electronics (formerly Versum Materials and Air Products Electronics division). She has been a key contributor to semiconductor materials growth, driving strong R&D to enable business success. Laura champions science and engineering talent, building teams to address global challenges with innovation and rigor. She serves on the boards of SEMI Impact for Skills and AIChE. She holds a Ph.D. in Analytical Chemistry from Washington State University and a bachelor’s from Indiana University of Pennsylvania.

Charity of the Year, 2026

"We are delighted to have been chosen as charity of the year for the 2026 Anglonordic Life Science conference. Barts Charity exists to support healthier, longer lives in East London, where our patients face some of the greatest health inequalities in the UK. Healthcare innovation is urgently needed, and this opportunity will help us build relationships with leading drug discovery and technology companies across the UK, Nordic and European regions, collaborating to accelerate discoveries and improved patient care."
- Fiona Miller-Smith, CEO at Barts Charity